AATD Physician Brochure

• Should Your Patient Be Tested
• Your Newly Diagnosed Patient
• Managing Your AAT Deficient Patient

This brochure is designed to help physicians with testing, diagnosis and management of AAT deficiency*.

*Also known as Alpha-1, alpha-1 antitrypsin deficiency, AATD, A1-PI deficiency, alpha-1 proteinase deficiency, A1AD, or hereditary or genetic emphysema.

It includes information about:

• Who Should be Tested for AAT Deficiency
• Diagnostic Processes
• Guidelines for Family Testing
• Therapeutic Options
• Augmentation Therapy
• Insurance Assistance

You may order the Physician Brochure online or by phone at 1-866-ARALAST (272-5278).

You may also download a copy of the brochure.

ARALAST [Alpha₁-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A₁-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A₁-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information